Michael Saccone
Analyst, Jefferies
Replay available
LeMaitre Vascular, Inc. (NASDAQ: LMAT) Q1 2025 earnings conference call, held 2025-05-15. Replay captured from the company's public earnings webcast.

Analyst, Jefferies
Chief Financial Officer
Chief Executive Officer
Analyst, Sidoti & Co.
President
Analyst, Cantor Fitzgerald
Analyst, KeyBank Capital Markets
Analyst, Stiefel
Watch the replay and follow the connected company analysis, news, and investor updates for Lemaitre Vascular, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.578 Welcome to the LeMaitre Vascular first quarter 2025 financial results conference call. 00:00:05.578 -- 00:00:08.442 As a reminder, today's call is being recorded. 00:00:08.442 -- 00:00:10.845 At this time, I would like to turn the call over to Mr. 00:00:10.845 -- 00:00:14.470 Dorian LeBlanc, Chief Financial Officer of LeMaitre Vascular. 00:00:14.470 -- 00:00:17.071 Please go ahead, sir. 00:00:18.716 -- 00:00:24.003 Thank you, operator. Good afternoon, and thank you for joining us on our Q1 2025 conference 00:00:24.003 -- 00:00:29.209 call. With me on today's call is our CEO, George LeMaitre, and our President, Dave 00:00:29.209 -- 00:00:33.576 Roberts. Before we begin, I'll read our safe harbor statement. 00:00:33.576 -- 00:00:36.961 Today we will make some forward-looking statements within the meaning of the U.S. 00:00:36.961 -- 00:00:42.109 Private Securities Litigation Reform Act of 1995, the accuracy of which is subject 00:00:42.109 -- 00:00:46.856 to risks and uncertainties. Wherever possible, we will try to identify these forward-looking 00:00:46.856 -- 00:00:52.905 statements by using words such as believe, expect, anticipate, pursue, forecast, 00:00:52.905 -- 00:00:56.971 and similar expressions. Our forward-looking statements are based on our estimates and 00:00:56.971 -- 00:01:01.211 assumptions as of today May 1, 2025, 00:01:01.314 -- 00:01:05.300 and should not be relied upon as representing our estimates or views on any subsequent 00:01:05.300 -- 00:01:07.202 date. 00:01:07.202 -- 00:01:10.868 Please refer to the cautionary statement regarding forward-looking information and the 00:01:10.868 -- 00:01:16.095 risk factors in our most recent 10-K and subsequent SEC filings, including 00:01:16.095 -- 00:01:20.642 disclosur...